DEDeborah dos Reis Estrella

Deborah dos Reis Estrella

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Deborah dos Reis Estrella has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Perfil epidemiológico dos pacientes atendidos em 2020 e 2021 com diagnóstico de COVID-19 em hospital particular de Belo Horizonte

    by Leonardo Meira de Faria, Maria Clara Miranda Lino, Pedro Henrique Andrade Benício, Laís Campolina Almeida, Deborah dos Reis Estrella, Bruno Porto Pessoa, Amanda Damasceno de Souza

    O objetivo foi descrever o perfil epidemiológico dos pacientes internados no Hospital Felício Rocho de Belo Horizonte, MG, com o diagnóstico positivo para a COVID-19 em categorias de sexo, idade, sintomas, passagem pelo CTI, necessidade de ventilação mecânica e desfecho. Trata-se de estudo retrospectivo epidemiológico conduzido em um hospital privado de grande porte em Belo Horizonte, com 3.034 pacientes diagnosticados com COVID-19 entre março de 2020 e dezembro de 2021. Variáveis consideradas: gênero, idade, sintomas, necessidade de terapia intensiva, ventilação mecânica e mortalidade. A análise descritiva utilizou a mediana para dados numéricos e frequências absolutas e relativas para variáveis categóricas. Os sintomas mais comuns em pacientes hospitalizados com COVID-19 incluem tosse, mialgia, cefaleia, febre, coriza, odinofagia, dispneia e diarreia. A tosse foi o sintoma mais prevalente entre os pacientes, enquanto outros estudos relataram febre, dispneia e taquicardia como os sintomas mais comuns. A necessidade de internação no CTI e uso de ventilação mecânica foram menores no hospital estudado em relação a outros estudos, assim como a média de idade dos pacientes. As limitações incluem a falta de informações sobre comorbidades e a contabilização de óbitos apenas após a passagem pelo CTI.


  • Concurrent validity between field tests and cardiopulmonary exercise testing in patients with idiopathic pulmonary fibrosis

    by Hugo Leonardo Alves Pereira, Eliane Viana Mancuzo, Giane Amorim Ribeiro-Samora, Anna Clara Albuquerque Pataro, Deborah dos Reis Estrella, Danielle Aparecida Gomes Pereira, Verônica Franco Parreira

    Maximal treadmill cardiopulmonary exercise testing is the gold standard for assessing functional capacity in patients with idiopathic pulmonary fibrosis (IPF). Primarily to investigate the concurrent validity between three field tests and cardiopulmonary exercise testing in these patients. Patients performed the cardiopulmonary exercise testing, a six-minute walk test, an incremental shuttle walk test, and, the Glittre-ADL test. For cardiopulmonary exercise testing, the ten seconds with the higher average of the peak oxygen uptake obtained within the last 30 seconds were considered; for six-minute walk test and incremental shuttle walk test, the longer distance; and for the Glittre-ADL test, the shorter time spent. Concurrent validity was assessed using different regression models based on the best adjustment of the data. Twenty-two patients with IPF were assessed, aged: 68 ± 8.1 years, 13 male. Patients presented a peak oxygen uptake of 16.5 ± 3.6 mL.kg-1.min1, achieving a distance of 512.6 ± 102.8 meters in the six-minute walk test and 415.7 ± 125.1 meters in incremental shuttle walk test. The walking distance in the six-minute walk test and the incremental shuttle walk test explained, respectively, 64% and 56% peak oxygen uptake variance observed in the cardiopulmonary exercise testing (R2 = 0.64,p < .001; R2 = 0.56,p < .001). The time spent in the Glittre-ADL test was 233.4 ± 88.7 seconds and explained 47% of the peak oxygen uptake variance observed in cardiopulmonary exercise testing (R2 = 0.47,p = .001). The six-minute walk test, incremental shuttle walk test, and Glittre-ADL test were considered valid tests to explain the peak oxygen uptake variance obtained by the cardiopulmonary exercise testing in patients with IPF.


  • Open Access

    Factors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients: a case-control study

    by Leonardo Meira de Faria, Vandack Nobre, Letícia Ribeiro de Oliveira Guardão, Camila Magalhães Souza, Amanda Damasceno de Souza, Deborah Dos Reis Estrella, Bruno Porto Pessoa, Ricardo Amorim Corrêa

    Objective: To evaluate the etiology of and factors associated with pulmonary infection in kidney and kidney-pancreas transplant recipients. Methods: This was a single-center case-control study conducted between December of 2017 and March of 2020 at a referral center for kidney transplantation in the city of Belo Horizonte, Brazil. The case:control ratio was 1:1.8. Cases included kidney or kidney-pancreas transplant recipients hospitalized with pulmonary infection. Controls included kidney or kidney-pancreas transplant recipients without pulmonary infection and matched to cases for sex, age group, and donor type (living or deceased). Results: A total of 197 patients were included in the study. Of those, 70 were cases and 127 were controls. The mean age was 55 years (for cases) and 53 years (for controls), with a predominance of males. Corticosteroid use, bronchiectasis, and being overweight were associated with pulmonary infection risk in the multivariate logistic regression model. The most common etiologic agent of infection was cytomegalovirus (in 14.3% of the cases), followed by Mycobacterium tuberculosis (in 10%), Histoplasma capsulatum (in 7.1%), and Pseudomonas aeruginosa (in 7.1%). Conclusions: Corticosteroid use, bronchiectasis, and being overweight appear to be risk factors for pulmonary infection in kidney/kidney-pancreas transplant recipients, endemic mycoses being prevalent in this population. Appropriate planning and follow-up play an important role in identifying kidney and kidney-pancreas transplant recipients at risk of pulmonary infection.


  • Open Access

    Use of antifibrotic drugs in familial interstitial pneumonia: analysis of one family

    by Deborah dos Reis Estrella, Eliane Viana Mancuzo, Ricardo de Amorim Correa